Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 “- (4”-amino-1“,2”-oxathiole-2“,2”-dioxide)thymine (TSAO-T).
Open Access
- 1 June 1992
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 267 (17) , 11831-11838
- https://doi.org/10.1016/s0021-9258(19)49774-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Gene organization and primary structure of a ribosomal RNA operon from Escherichia coliPublished by Elsevier ,2004
- Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogs: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activityJournal of Medicinal Chemistry, 1992
- A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templatesAntiviral Research, 1991
- Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivativesJournal of Medicinal Chemistry, 1991
- Molecular structure of a potent HIV-1 inhibitor belonging to the TIBO familyJournal of the American Chemical Society, 1991
- Characterization of the human immunodeficiency virus type-1 reverse transcriptase enzyme produced in yeastBiochemical and Biophysical Research Communications, 1990
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989
- Synthesis and antiviral activity of several 2,5'-anhydro analogs of 3'-azido-3'-deoxythymidine (AZT), 3'-azido-2',3'-dideoxyuridine (AZU), 3'-azido-2',3'-dideoxy-5-halouridines, and 3'-deoxythymidine against human immunodeficiency virus (HIV-1) and Rauscher-Murine leukemia virus (R-MuLV)Journal of Medicinal Chemistry, 1989
- Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cellsJournal of Medicinal Chemistry, 1989
- Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidineBiochemical and Biophysical Research Communications, 1986